DK0953630T3 - Omesterificeringsprodukter af majsolie og glycerol og deres anvendelse i farmaceutiske sammensætninger - Google Patents

Omesterificeringsprodukter af majsolie og glycerol og deres anvendelse i farmaceutiske sammensætninger

Info

Publication number
DK0953630T3
DK0953630T3 DK99106122T DK99106122T DK0953630T3 DK 0953630 T3 DK0953630 T3 DK 0953630T3 DK 99106122 T DK99106122 T DK 99106122T DK 99106122 T DK99106122 T DK 99106122T DK 0953630 T3 DK0953630 T3 DK 0953630T3
Authority
DK
Denmark
Prior art keywords
glycerol
pharmaceutical compositions
corn oil
rearranging products
rearranging
Prior art date
Application number
DK99106122T
Other languages
Danish (da)
English (en)
Inventor
Armin Meinzer
Birgit Hauer
Ulrich Posanski
Jacky Vonderscher
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0953630(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0953630T3 publication Critical patent/DK0953630T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
DK99106122T 1991-06-27 1992-06-23 Omesterificeringsprodukter af majsolie og glycerol og deres anvendelse i farmaceutiske sammensætninger DK0953630T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds
EP92810479A EP0539319B1 (en) 1991-06-27 1992-06-23 Pharmaceutical cyclosporin composition

Publications (1)

Publication Number Publication Date
DK0953630T3 true DK0953630T3 (da) 2004-11-01

Family

ID=10697415

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99106122T DK0953630T3 (da) 1991-06-27 1992-06-23 Omesterificeringsprodukter af majsolie og glycerol og deres anvendelse i farmaceutiske sammensætninger
DK92810479T DK0539319T3 (da) 1991-06-27 1992-06-23 Farmaceutisk cyclosporinpræparat

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92810479T DK0539319T3 (da) 1991-06-27 1992-06-23 Farmaceutisk cyclosporinpræparat

Country Status (38)

Country Link
EP (2) EP0953630B1 (cs)
JP (2) JP2653958B2 (cs)
KR (3) KR0131064B1 (cs)
CN (1) CN1077798C (cs)
AT (1) AT403436B (cs)
AU (1) AU659460B2 (cs)
CA (2) CA2175842C (cs)
CH (2) CH684163A5 (cs)
CY (1) CY1906A (cs)
CZ (1) CZ281790B6 (cs)
DE (3) DE4244930C2 (cs)
DK (2) DK0953630T3 (cs)
EE (1) EE03108B1 (cs)
ES (2) ES2227921T3 (cs)
FI (2) FI109454B (cs)
FR (2) FR2678169B1 (cs)
GB (2) GB9113872D0 (cs)
GR (1) GR3032366T3 (cs)
HK (2) HK57196A (cs)
HU (1) HU216792B (cs)
IE (1) IE73662B1 (cs)
IL (3) IL118546A (cs)
IT (1) IT1254401B (cs)
LU (1) LU88138A1 (cs)
MX (1) MX9203236A (cs)
MY (1) MY109512A (cs)
NO (2) NO303964B1 (cs)
NZ (1) NZ243309A (cs)
PH (1) PH30337A (cs)
PT (2) PT539319E (cs)
RO (2) RO111021B1 (cs)
RU (1) RU2143919C1 (cs)
SA (1) SA92130213B1 (cs)
SK (1) SK278759B6 (cs)
TW (1) TW267943B (cs)
UA (1) UA35559C2 (cs)
UY (1) UY23864A1 (cs)
ZA (1) ZA924719B (cs)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
DK0589843T3 (da) * 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
EP1033128B2 (en) 1993-09-28 2011-11-23 R.P. Scherer GmbH Soft gelatin capsule manufacture
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
EP0694308A4 (en) * 1994-02-17 1997-09-10 Shiseido Co Ltd CYCLOSPORIN EMULSION COMPOSITION
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
DK0679712T3 (da) * 1994-03-31 2000-01-03 Unilever Nv Olier med lavt indhold af mættede fedtsyrer (SAFA)
PE52896A1 (es) 1994-10-26 1996-12-12 Novartis Ag Composicion farmaceutica
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
EP0789580B1 (de) 1994-11-03 2002-06-05 Novartis AG Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
JPH11505258A (ja) * 1995-05-17 1999-05-18 セダーシナイ メディカル センター 小腸における消化および吸収を改善させる脂肪酸を含む組成物
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19549852B4 (de) 1995-11-29 2009-06-04 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
NZ330062A (en) * 1996-06-19 2000-01-28 Novartis Ag composition containing cyclosporin, propylene carbonate, an oil component and a surfactant
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
WO1999027946A1 (en) * 1997-12-02 1999-06-10 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
TR199902199T2 (xx) * 1997-03-12 2002-06-21 Abbott Laboratories Siklosporin tatbiki i�in hidrofilik ikili sistemler.
CA2285983A1 (en) 1997-04-29 1998-11-05 Bernard Charles Sherman Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
ES2174462T3 (es) * 1997-07-29 2002-11-01 Upjohn Co Formulacion autoestimulante para compuestos lipofilos.
EP0999826B1 (en) * 1997-07-29 2004-05-06 PHARMACIA & UPJOHN COMPANY Self-emulsifying formulation for lipophilic compounds
US6231887B1 (en) 1997-07-29 2001-05-15 Pharmacia & Upjohn Company Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
EP1023441A1 (en) 1997-10-16 2000-08-02 The Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
AU743098B2 (en) 1997-12-10 2002-01-17 Cyclosporine Therapeutics Limited Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP0982035B1 (en) * 1998-08-18 2004-03-31 Panacea Biotec Limited Cyclosporin composition comprising an hydrophilic carrier
CA2354233A1 (en) * 1998-12-11 2000-06-15 Pharmasolutions, Inc. Self-emulsifying compositions for drugs poorly soluble in water
WO2000040219A1 (en) 1998-12-30 2000-07-13 Dexcel Ltd. Dispersible concentrate for the delivery of cyclosporin
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
AU2127400A (en) * 1999-11-02 2001-05-14 Cipla Limited A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
US7008661B2 (en) 2000-08-08 2006-03-07 Kao Corporation Oil/fat composition
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
ES2330625T3 (es) 2001-10-19 2009-12-14 Isotechnika Inc. Preconcentrados de microemulsion de analogos de ciclosporina novedosos.
NZ531944A (en) 2001-10-19 2006-03-31 Isotechnika Inc Synthesis of cyclosporin analogs
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
HRP20130173T1 (hr) 2007-04-04 2013-04-30 Sigmoid Pharma Limited Farmaceutske formulacije ciklosporina
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
HRP20150110T1 (hr) 2009-05-18 2015-05-08 Sigmoid Pharma Limited Kompozicija koja sadrži uljne kapljice
JP5911799B2 (ja) 2009-08-12 2016-04-27 シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ ポリマーマトリックスおよび油相を含んで成る免疫調節組成物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
KR20170102223A (ko) 2014-11-07 2017-09-08 시그모이드 파마 리미티드 사이클로스포린을 포함하는 조성물
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
PL3886813T3 (pl) * 2018-11-26 2023-06-19 Hepion Pharmaceuticals, Inc. Postacie farmaceutyczne analogów cyklosporyny

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FR2344283A1 (fr) * 1976-03-17 1977-10-14 Gattefosse Ets Sa Nouveau melange de glycerides utile comme nutriment lipidique
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE3444893A1 (de) * 1984-12-08 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von fettsaeuremethylestern
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (cs) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
GB2230440B (en) * 1989-02-09 1993-05-19 Sandoz Ltd Novel cyclosporin galenic forms
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EE03108B1 (et) 1998-08-17
EP0539319A3 (en) 1993-06-09
FI961513L (fi) 1996-04-03
ITRM920476A1 (it) 1993-12-23
JPH05186365A (ja) 1993-07-27
SK278759B6 (sk) 1998-02-04
EP0953630A1 (en) 1999-11-03
IT1254401B (it) 1995-09-14
AT403436B (de) 1998-02-25
IL102310A (en) 1997-03-18
ZA924719B (en) 1993-12-27
ES2142818T3 (es) 2000-05-01
UY23864A1 (es) 1995-05-29
GB2257359B (en) 1996-01-10
FR2685706A1 (fr) 1993-07-02
AU1852792A (en) 1993-03-11
FI116199B (fi) 2005-10-14
NO325267B1 (no) 2008-03-17
CH685764A5 (de) 1995-09-29
GB9113872D0 (en) 1991-08-14
FI922958A0 (fi) 1992-06-25
HU216792B (hu) 1999-08-30
KR100231385B1 (en) 1999-11-15
AU659460B2 (en) 1995-05-18
GB2257359A (en) 1993-01-13
NO964382L (no) 1992-12-28
CA2072509C (en) 1996-07-30
PT539319E (pt) 2000-05-31
CZ197792A3 (en) 1993-01-13
HK57196A (en) 1996-04-12
JPH09118894A (ja) 1997-05-06
NO922506L (no) 1992-12-28
EP0953630B1 (en) 2004-09-08
HK157696A (en) 1996-08-30
FR2678169A1 (fr) 1992-12-31
CH684163A5 (de) 1994-07-29
ES2227921T3 (es) 2005-04-01
FI109454B (fi) 2002-08-15
HUT62201A (en) 1993-04-28
RU2143919C1 (ru) 2000-01-10
JP3420897B2 (ja) 2003-06-30
FI961513A0 (fi) 1996-04-03
NZ243309A (en) 1995-02-24
FI922958L (fi) 1992-12-28
IE73662B1 (en) 1997-06-18
DE4244986B4 (de) 2008-07-24
DE4244930C2 (de) 1999-11-11
HU9201975D0 (en) 1992-09-28
FR2685706B1 (cs) 1994-12-23
FR2678169B1 (fr) 1994-08-26
NO922506D0 (no) 1992-06-25
CA2175842A1 (en) 1992-12-28
KR0131064B1 (ko) 1998-04-17
DE4219526C2 (de) 1999-04-22
LU88138A1 (fr) 1994-03-01
TW267943B (cs) 1996-01-11
RO111110B1 (ro) 1996-06-28
GB9213393D0 (en) 1992-08-05
GR3032366T3 (en) 2000-04-27
IL118546A (en) 1998-09-24
IL102310A0 (en) 1993-01-14
CA2175842C (en) 2002-05-07
CN1077798C (zh) 2002-01-16
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
CZ281790B6 (cs) 1997-01-15
JP2653958B2 (ja) 1997-09-17
CY1906A (en) 1992-06-24
NO303964B1 (no) 1998-10-05
KR930000113A (ko) 1993-01-15
ATA129892A (de) 1997-07-15
EP0539319A2 (en) 1993-04-28
PH30337A (en) 1997-04-02
EP0539319B1 (en) 1999-12-08
KR100231384B1 (en) 1999-11-15
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
DK0539319T3 (da) 2000-05-22
SK197792A3 (en) 1994-03-09
CA2072509A1 (en) 1992-12-28
RO111021B1 (ro) 1996-06-28
DE4219526A1 (de) 1993-03-18
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
NO964382D0 (no) 1996-10-15
CN1079907A (zh) 1993-12-29
PT953630E (pt) 2004-11-30
IL118546A0 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
DK0953630T3 (da) Omesterificeringsprodukter af majsolie og glycerol og deres anvendelse i farmaceutiske sammensætninger
NO941929D0 (no) Tokotrienoler og tokotrienol-lignende sammensetninger og fremgangsmåter for deres anvendelse
BR9609951A (pt) Novas composições farmacêuticas e seu uso
DK1023900T3 (da) Farmaceutisk præparat indeholdende S-nitroso-lipoproteiner og anvendelse deraf
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
NO921012D0 (no) Farmasoeytiske preparater og deres anvendelse
FI20002197L (fi) Hitaasti vapauttava kapseli ja hitaasti vapauttavia formulaatioita
FI960892L (fi) Polymeerimatriisit ja niiden käyttö farmaseuttisissa koostumuksissa
FI934274A7 (fi) N-sulfonyyli-2-oksi-indolijohdannaiset, niiden valmistus ja niitä sisä ltävät farmaseuttiset koostumukset
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
FI945731A0 (fi) Tiatsolidiinijohdannaiset ja farmaseuttiset koostumukset, jotka sisältävät niitä
FI935074A7 (fi) Uusia tiopyranopyrrolijohdannaisia ja niiden valmistus
FI961418A7 (fi) Atsolijohdannainen ja sen farmaseuttinen seos
BR9200058A (pt) Composto e composicao farmaceutica
NO914049L (no) Materialer som kan anvendes som saarbandasjer og for administrering av medikamenter
LV10386A (lv) Farmaceitiska kompozicija un tas pagatavosanas panemiens
DK204291D0 (da) Heterocykliske forbindelser deres fremstilling og anvendelse
FI960487A7 (fi) Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia
NO924528L (no) Derivater av humant gallesalt-stimulert lipase og farmasoeytiske sammensetninger som inneholder disse
MX9100742A (es) Composicion farmaceutica y procedimiento para su preparacion
DK0508334T3 (da) Aminophenolderivater og farmaceutiske præparater indeholdende disse
BR8905444A (pt) Composicoes e aplicacao
FI941517A7 (fi) Bentsonaftyridiinin-1,8 johdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
FI941958A7 (fi) 2-heterosyklinenetyyliamiinijohdannaiset ja niiden käyttö lääkkeinä
ITMI910359A0 (it) Impiego medicamentoso di derivati diidropiridinici